TropIQ combines world-class parasitological expertise with state of the art drug discovery technologies. Through this combination, TropIQ is uniquely positioned to accelerate the development of malaria-eradicating drugs. The company was founded in 2011 as a spin-off of the Radboud university medical center in the Netherlands (Nijmegen).